{"id":"W4220833656","doi":"10.1158/1538-7445.sabcs21-p4-10-01","title":"Abstract P4-10-01: Quality of life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Palbociclib; Breast cancer; Clinical endpoint; Quality of life (healthcare); Internal medicine; Adjuvant; Cancer; Randomized controlled trial; Interim analysis; Adjuvant therapy; Oncology; Metastatic breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004823742,0.0002338651,0.001278,0.0003236414,0.0001111218,0.00001781041,0.0003726267,0.00005747156,0.001297071],"category_scores_gemma":[0.0002211096,0.00015061,0.0001314649,0.001012452,0.0008733234,0.0001273007,0.0001403988,0.001020195,5.83759e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004097752,"about_ca_system_score_gemma":0.001303689,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03744007,"about_ca_topic_score_gemma":0.003176627,"domain_scores_codex":[0.9948854,0.001575097,0.0008441004,0.0004733232,0.001635358,0.0005867458],"domain_scores_gemma":[0.9972234,0.001447979,0.0003100697,0.0005593106,0.0003221638,0.0001371158],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9210559,0.0005913534,0.05016932,0.0002633503,0.0002348454,0.00003590445,0.004063926,0.0001348155,0.006317263,0.0001015313,0.00006829322,0.01696357],"study_design_scores_gemma":[0.6011006,0.0007572378,0.3946906,0.0001974939,0.00001667539,0.00001577913,0.001350793,0.00001829436,0.0008765665,0.0002674695,0.000552077,0.0001564594],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9857426,0.006339484,0.000003030378,0.00426706,0.00008363792,0.003082484,0.00027181,0.00001389264,0.0001960538],"genre_scores_gemma":[0.9936938,0.003121203,0.00002697761,0.0002260577,0.0001734063,0.002583328,0.00001079929,0.00003961839,0.0001248333],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3445213,"threshold_uncertainty_score":0.9996159,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07693271054620061,"score_gpt":0.422743662923142,"score_spread":0.3458109523769414,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}